Key Developments: Smith & Nephew PLC (SNN.N)

SNN.N on New York Stock Exchange

22 Jul 2014
Price Change (% chg)

$0.71 (+0.80%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

Smith & Nephew PLC announces appointment of new auditors
Friday, 11 Jul 2014 

Smith & Nephew PLC:Appointment of KPMG LLP (KPMG) as its auditor for year ending Dec .31, 2015, subject to approval by shareholders at 2015 AGM.  Full Article

Smith & Nephew PLC enters commercial agreement to bring robotic navigation to JOURNEY UNI Knee procedure
Thursday, 10 Jul 2014 

Smith & Nephew PLC:Says new commercial agreement with Blue Belt Technologies.Under this agreement, surgeons using Navio system will be able to implant Smith & Nephew's JOURNEY UNI partial knee.  Full Article

Smith & Nephew PLC completes acquisition of ArthroCare
Thursday, 29 May 2014 

Smith & Nephew PLC:Completes acquisition of ArthroCare Corporation.Purchase price was $48.25 per share paid in cash, translating into an enterprise value of about $1.5 bln.  Full Article

Smith & Nephew PLC fixes record and payment date for dividend
Friday, 25 Apr 2014 

Smith & Nephew PLC:As announced on Feb. 06, 2014, final dividend of $0.17 per share per ordinary share in respect of the year ended Dec. 31, 2013.Payable on May 07.Record date is April 22.  Full Article

Smith & Nephew plc launches JOURNEY II Cruciate Retaining natural-motion knee replacement
Wednesday, 12 Mar 2014 

Smith & Nephew plc:Launches JOURNEY II Cruciate Retaining (CR) knee replacement at American Academy of Orthopaedic Surgeons (AAOS) meeting in New Orleans.New implant extends JOURNEY II Total Knee System to procedures that preserve posterior cruciate ligament (PCL), which accounts for about half of all knee replacement procedures.  Full Article

Smith & Nephew and OrthoSensor to co-market VERASENSE Sensor Assisted Surgery with JOURNEY II and LEGION Total Knee Replacements
Monday, 10 Mar 2014 

Smith & Nephew PlC and OrthoSensor:Agreement that will enable surgeons to benefit from OrthoSensor's VERASENSE Sensor Assisted Surgery Technology for soft tissue balancing when implanting Smith & Nephew's JOURNEY II and LEGION Total Knee Systems.VERASENSE utilizes advanced sensor technologies to enable evidence-based surgical decisions regarding component position, limb alignment and soft tissue balance to optimize outcomes in total knee replacement.  Full Article

Smith & Nephew PLC recommends final dividend
Thursday, 6 Feb 2014 

Smith & Nephew PLC:Recommends a final dividend of $0.17 per share ($0.85 per ADS).This, together with interim dividend of $0.104 per share ($0.52 per ADS), will give a full year distribution of $0.274 per share ($0.137 per ADS), up five pct year-on-year.  Full Article

Smith & Nephew PLC announces acquisition
Monday, 3 Feb 2014 

Smith & Nephew PLC:Executes a definitive agreement to acquire medical device company, ArthroCare Corp. for $48.25 per ArthroCare share in cash.Says total consideration is about $1.7 billion and an enterprise value of $1.5 billion.  Full Article

Smith & Nephew PLC to acquire Brazilian distribution of its advanced wound management products
Tuesday, 26 Nov 2013 

Smith & Nephew PLC:Says it has agreed to acquire the assets and business of Politec Saude relating to Smith & Nephew PLC's advanced wound management products in Brazil.Says it is planned that 30 employees will transfer to Smith & Nephew PLC Brazil upon completion of the deal.Says further terms of the transaction have not been disclosed.  Full Article

Smith & Nephew PLC Announces Appointment Of Chairman Elect
Thursday, 31 Oct 2013 

Smith & Nephew PLC announced the appointment of Roberto Quarta as Non-Executive Director and Chairman Elect. He will join the Board on December 4, 2013 and will offer himself for re-election at the Company's Annual General Meeting to be held on April 10, 2014. Subject to his re-election, he will be appointed Chairman to succeed Sir John Buchanan, who joined the Board in 2005 and has been Chairman since 2006, and who will retire from the Board at the same time.  Full Article


Shire ready to bow to AbbVie's increased $53 billion offer

LONDON - London-listed drugmaker Shire Plc succumbed to an increased 31 billion pounds ($53 billion) takeover offer from Abbvie Inc on Monday, signaling the conclusion to a long-running courtship largely motivated by tax. | Video

Search Stocks